Back to search

United Kingdom· GB-APID-30820211000001105

Fibrogammin 1,250unit powder and solvent for solution for injection vials

A medicinal product containing factor xiii, registered in United Kingdom by CSL Behring UK Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedFibrogammin 1,250unit powder and solv…ATC—REGISTER NO.GB-APID-3082021100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Factor XIII
Manufacturer
CSL Behring UK Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5028360000008

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2a4520f-38ad-417c-b815-40d5c4b571e8
GET /v1/drugs/f2a4520f-38ad-417c-b815-40d5c4b571e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "30820211000001105",
  "desc": "Fibrogammin 1,250unit powder and solvent for solution for injection vials (CSL Behring UK Ltd)",
  "form": "Powder and solvent for solution for injection",
  "vpid": "36066311000001101",
  "source": "dmd",
  "vtm_id": "775331003",
  "strength": "1250 unit",
  "substance": "Factor XIII",
  "ingredient": "Factor XIII",
  "supplier_code": "9364911000001100"
}

See everything about factor xiii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.